A Phase II Trial of Neoadjuvant Docetaxel/5-Fu/cisplatin in Combination with Prophylactic Pegteograstim in Unresectable, Locally Advanced Nasal Cavity/paranasal Squamous Cell Carcinoma: KCSG HN18-07.
Cancer Research and Treatment（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined